Spyre Therapeutics, Inc.

MILLENNIUM MANAGEMENT LLC SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

2,453,221

Value ($000)

1,105

Weight

0.0%

2020 Q1 - 2023 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	1,105	0.0%	2,453,221	6/30/2023
2023 Q1	5/15/2023	1,084	0.0%	3,736,483	3/31/2023
2022 Q4	2/14/2023	1,409	0.0%	3,131,479	12/31/2022
2022 Q3	11/14/2022	429	0.0%	814,672	9/30/2022
2022 Q2	8/15/2022	264	0.0%	521,915	6/30/2022
2022 Q1	5/16/2022	975	0.0%	423,914	3/31/2022
2021 Q4	2/14/2022	905	0.0%	190,482	12/31/2021
2021 Q3	11/15/2021	4,255	0.0%	535,222	9/30/2021
2021 Q2	8/16/2021	3,781	0.0%	543,185	6/30/2021
2021 Q1	5/17/2021	2,939	0.0%	371,136	3/31/2021
2020 Q4	2/16/2021	3,614	0.0%	459,158	12/31/2020
2020 Q3	11/16/2020	386	0.0%	54,511	9/30/2020
2020 Q2	8/14/2020	1,697	0.0%	183,450	6/30/2020
2020 Q1	5/14/2020	65	0.0%	13,934	3/31/2020